Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins

Micro-RNAs (miRs) represent an innovative class of genes that act as regulators of gene expression. Recently, the aberrant expression of several miRs has been associated with different types of cancers. In this study, we show that miR301 inhibition influences PI3K-Akt pathway activity. Akt overexpression in MCF7 and MDAMB468 cells caused downregulation of miR301 expression. This effect was confirmed by co-transfection of miR301-modulators in the presence of Akt. Cells overexpressing miR301-inhibitor and Akt, exhibited increased migration and proliferation. Experimental results also confirmed PI3K, PTEN and FoxF2 as regulatory targets for miR301. Furthermore, Akt expression in conjunction with miR301-inhibitor increased nuclear accumulation of PTEN, thus preventing it from downregulating the PI3K-signalling. In summary, our data emphasize the importance of miR301 inhibition on PI3K-Akt pathway-mediated cellular functions. Hence, it opens new avenues for the development of new anti-cancer agents preferentially targeting PI3K-Akt pathway.

[1]  J. Davoodi,et al.  Role of the salt bridge between glutamate 546 and arginine 907 in preservation of autoinhibited form of Apaf-1. , 2015, International journal of biological macromolecules.

[2]  Chen Li,et al.  Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease , 2015, Bioscience reports.

[3]  Marek J. Łos,et al.  Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21Waf1/Cip1 and p27kip1 , 2015, Cell cycle.

[4]  Zhongxin Lu,et al.  Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer , 2015, Cell Discovery.

[5]  Da-Wei Li,et al.  MiR-300 regulate the malignancy of breast cancer by targeting p53. , 2015, International journal of clinical and experimental medicine.

[6]  Marek J. Łos,et al.  Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death , 2015, Oncotarget.

[7]  Wiem Chaabane,et al.  Human-Gyrovirus-Apoptin Triggers Mitochondrial Death Pathway—Nur77 is Required for Apoptosis Triggering , 2014, Neoplasia.

[8]  S. Lawler,et al.  MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.

[9]  Stephen L. Abrams,et al.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention , 2014, Oncotarget.

[10]  K. Magnusson,et al.  Cell type related differences in staining with pentameric thiophene derivatives , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  S. Ghavami,et al.  Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. , 2014, Biochimica et biophysica acta.

[12]  C. Lengerke,et al.  Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development , 2013, Journal of cellular and molecular medicine.

[13]  T. Zhu,et al.  MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression , 2012, PloS one.

[14]  Davide Altomare,et al.  Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling , 2012, Current medicinal chemistry.

[15]  P. Neilsen,et al.  The Oncogenic Role of miR-155 in Breast Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[16]  T. Huang,et al.  Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development , 2012, Breast Cancer Research.

[17]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[18]  Anthony Fyles,et al.  MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.

[19]  S. Leung,et al.  Biomarkers , Genomics , Proteomics , and Gene Regulation Subcellular Localization of Activated AKT in Estrogen Receptor-and Progesterone Receptor-Expressing Breast Cancers Potential Clinical Implications , 2010 .

[20]  Stefano Piccolo,et al.  MicroRNA control of signal transduction , 2010, Nature Reviews Molecular Cell Biology.

[21]  Li Xie,et al.  MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression , 2010, Journal of experimental & clinical cancer research : CR.

[22]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[23]  K. Schulze-Osthoff,et al.  Switching Akt: from survival signaling to deadly response , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  I. Gérin,et al.  On the Role of FOX Transcription Factors in Adipocyte Differentiation and Insulin-stimulated Glucose Uptake* , 2009, Journal of Biological Chemistry.

[25]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[26]  James W Jacobson,et al.  MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis. , 2007, Cancer research.

[27]  B. Pogo,et al.  Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells. , 2007, Oncology reports.

[28]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[29]  S. Baker.  PTEN Enters the Nuclear Age , 2007, Cell.

[30]  C. Downes,et al.  Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression , 2006, Journal of Cell Science.

[31]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[32]  T. Dalmay,et al.  MicroRNAs and the hallmarks of cancer , 2006, Oncogene.

[33]  V. Velculescu,et al.  Implications of micro-RNA profiling for cancer diagnosis , 2006, Oncogene.

[34]  A. Martelli,et al.  Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? , 2006, Cellular signalling.

[35]  P. Carlsson,et al.  Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production , 2006, Development.

[36]  Antonio Di Cristofano,et al.  Class reunion: PTEN joins the nuclear crew , 2005, Oncogene.

[37]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[38]  C. Chung,et al.  Akt‐induced promotion of cell‐cycle progression at G2/M phase involves upregulation of NF‐Y binding activity in PC12 cells , 2005, Journal of cellular physiology.

[39]  J. Downward.  PI 3-kinase, Akt and cell survival. , 2004, Seminars in cell & developmental biology.

[40]  P. Dennis,et al.  Activation of the PI3K/Akt pathway and chemotherapeutic resistance. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[41]  Carlos L. Arteaga,et al.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization , 2002, Nature Medicine.

[42]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[43]  P. Bendahl,et al.  Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. , 2002, Cancer research.

[44]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[45]  M. Hung,et al.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.

[46]  T. Pawson,et al.  Protein-protein interactions define specificity in signal transduction. , 2000, Genes & development.

[47]  J. Slingerland,et al.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest , 2002, Nature Medicine.